Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-02-08

Clinical Trial Update: Use of Self-management Group to Improve Quality of Life in Patients With Low Vision [NA]

View source ↗

Summary

The clinical trial examining a self-management group to improve quality of life in patients with age-related macular degeneration has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Age Related Macular Degeneration | NA | Status: WITHDRAWN